Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 8,408 |
|
|||||
| News | - | ||||||
| Day High | 2.24 | Low High |
|||||
| Day Low | 2.11 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Genprex Inc | GNPX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.09 | -4.07% | 2.12 | 16:32:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.16 | 2.11 | 2.24 | 2.12 | 2.21 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 140 | 8,408 | $ 2.15 | $ 18,118 | - | 2.09 - 42.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:02:05 | 50 | $ 2.18 | USD |
Genprex Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.27M | 1.49M | - | 0 | -30.86M | -20.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Genprex News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GNPX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.26 | 2.50 | 2.09 | 2.20 | 25,012 | -0.14 | -6.19% |
| 1 Month | 2.76 | 3.27 | 2.09 | 2.78 | 38,220 | -0.64 | -23.19% |
| 3 Months | 7.80 | 8.396 | 2.09 | 5.58 | 126,864 | -5.68 | -72.82% |
| 6 Months | 9.16 | 14.796 | 2.09 | 8.84 | 329,915 | -7.04 | -76.86% |
| 1 Year | 34.40 | 42.40 | 2.09 | 21.01 | 414,454 | -32.28 | -93.84% |
| 3 Years | 155.20 | 166.40 | 2.09 | 98.03 | 862,598 | -153.08 | -98.63% |
| 5 Years | 72.00 | 308.80 | 2.09 | 117.67 | 1,275,402 | -69.88 | -97.06% |
Genprex Description
| Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex's oncology program utilizes its systemic, non-viral Oncoprex® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor. |
